Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLong-Term Debt IssuancesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Orthofix Medical (OFIX) Depreciation & Amortization (IS) (2018 - 2026)

Orthofix Medical has reported Depreciation & Amortization (IS) over the past 8 years, most recently at $13.5 million for Q1 2026.

  • For the quarter ending Q1 2026, Depreciation & Amortization (IS) fell 60.81% year-over-year to $13.5 million, compared with a TTM value of $77.7 million through Mar 2026, up 9.4%, and an annual FY2023 reading of $53.1 million, up 82.86% over the prior year.
  • Depreciation & Amortization (IS) came in at $13.5 million for Q1 2026, up from $12.9 million in the prior quarter.
  • In the past five years, Depreciation & Amortization (IS) ranged from a high of $34.4 million in Q1 2025 to a low of $6.5 million in Q2 2022.
  • Median Depreciation & Amortization (IS) over the past 4 years was $13.2 million (2025), compared with a mean of $13.6 million.
  • The sharpest move saw Depreciation & Amortization (IS) crashed 61.35% in 2022, then grew 20.23% in 2025.
  • Over 4 years, Depreciation & Amortization (IS) stood at $7.4 million in 2022, then surged by 104.46% to $15.2 million in 2024, then fell by 14.71% to $12.9 million in 2025, then rose by 4.27% to $13.5 million in 2026.
  • Per Business Quant, the three most recent readings for OFIX's Depreciation & Amortization (IS) are $13.5 million (Q1 2026), $12.9 million (Q3 2025), and $16.9 million (Q2 2025).